Swiss National Bank’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Swiss National Bank’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,207	Closed	-$322K	–	2741
2022 Q3	$322K	Hold	15,207	–	–	﹤0.01%	2661
2022 Q2	$369K	Buy	15,207 +1,014	+7%	+$34.5K	﹤0.01%	2678
2022 Q1	$707K	Buy	14,193 +1,090	+8%	+$53.9K	﹤0.01%	2523
2021 Q4	$920K	Hold	13,103	–	–	﹤0.01%	2511
2021 Q3	$1.22M	Buy	13,103 +653	+5%	+$62K	﹤0.01%	2339
2021 Q2	$1.25M	Sell	12,450 -457	-4%	-$44.5K	﹤0.01%	2372
2021 Q1	$1.2M	Buy	12,907 +710	+6%	+$72K	﹤0.01%	2278
2020 Q4	$1.01M	Buy	+12,197	New	+$1.04M	﹤0.01%	2283

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swiss National Bank's VBIV Position: Q4 2022 in Review

Swiss National Bank sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 15,207 shares — an estimated $322K sold.

Swiss National Bank first reported a position in VBIV in Q4 2020 and held it in 8 quarters. The position peaked at $1.25M in Q2 2021. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

Swiss National Bank reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
Swiss National Bank sold 15,207 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $322K.
Swiss National Bank first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 8 quarters.
Swiss National Bank's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.25M in Q2 2021.
112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.